Understanding the role of VEGF in scar formation
了解 VEGF 在疤痕形成中的作用
基本信息
- 批准号:10303382
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAngiogenic FactorApoptosisAreaBehaviorBlood VesselsCellsCicatrixClinicalCollagenComplicationDataDefectDepositionDermalEmbryoEndothelial CellsEstheticsFibroblastsFibrosisGenerationsHealth Care CostsIn VitroInjuryKDR geneKnockout MiceKnowledgeLinkMediator of activation proteinMitogensMusMyofibroblastNutrientOperative Surgical ProceduresOrganOxygenPatientsPlayProcessProductionRegulationRoleSignal TransductionSiteSkinSkin wound healingSurgical incisionsTestingTimeTissuesVEGFA geneVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth FactorsWound modelsangiogenesisbasecell typecombatconditional knockouthealinghigh rewardhigh riskin vivointerestmigrationmouse modelnovelnovel therapeuticspreventpsychosocialreceptorrepairedskin woundtoolwoundwound healing
项目摘要
PROJECT SUMMARY:
Complications in the wound repair process, including the formation of excessive or abnormal scar
formation, affect millions of patients and result in substantial health care costs. Scar tissue impedes normal
skin function and can have severe psychosocial consequences. The ability to limit the amount of scar tissue
that forms following injury or surgical procedures would be a major clinical advance that would have a
tremendous impact on patients. In order to develop novel therapies to combat scarring, a more precise
understanding of the mechanisms that regulate scar formation is needed.
A growing body of evidence is emerging suggesting that the pro-angiogenic growth factor vascular
endothelial growth factor-A (VEGF) promotes scar formation. However, little has been done to dissect the
mechanisms by which VEGF contributes to scarring. Our preliminary data suggest that fibroblasts, the cell type
responsible for scar formation, express VEGF receptors and that cultured fibroblasts respond directly to VEGF.
Therefore, it is possible that in addition to regulating wound angiogenesis, VEGF may also directly stimulate to
scar formation by signaling through VEGFR-1 and/or VEGFR-2 in dermal fibroblasts.
Based on the evidence suggesting that VEGF promotes scar formation as well as preliminary data
suggesting that VEGF receptors are present on dermal fibroblasts and that these cells can respond to VEGF,
the central hypothesis of the proposed studies is that VEGF promotes scar tissue deposition through direct
stimulation of dermal fibroblasts. The following specific aims will be carried out to test this hypothesis: Aim 1 –
Assess the effects of VEGF on fibroblast function in vitro; Aim 2 – Determine the effects of VEGF on fibroblast
function in vivo.
Despite the mounting evidence that VEGF regulates scar formation, no detailed mechanistic studies have
been performed. Here, novel mouse models will be used to address this gap in knowledge by characterizing
direct effects of VEGF on fibroblasts and dissecting the mechanisms by which VEGF promotes scar formation.
The mechanisms identified as a result of these studies could extend beyond wound-induced scar formation,
and have the potential to also play a role in the regulation of fibrosis in the skin as well as other organs.
项目摘要:
伤口修复过程中的并发症,包括形成过量或异常疤痕
形成,影响数百万患者,并导致大量的医疗保健费用。疤痕组织阻碍正常
皮肤功能,可能会带来严重的社会心理后果。限制疤痕组织量的能力
受伤或手术程序后的形式将是一个主要的临床进展
对患者的巨大影响。为了开发新的疗法来打击疤痕,更精确
需要了解调节疤痕形成的机制。
越来越多的证据正在出现,表明促血管生长因子血管
内皮生长因子-A(VEGF)促进形成疤痕。但是,几乎没有做任何事情来剖析
VEGF有助于疤痕的机制。我们的初步数据表明成纤维细胞,细胞类型
负责疤痕形成,明确的VEGF接收器以及培养的成纤维细胞直接对VEGF做出反应。
因此,除了调节伤口血管生成外,VEGF还可能直接刺激
通过在皮肤成纤维细胞中通过VEGFR-1和/或VEGFR-2发出信号来形成疤痕。
基于证据表明VEGF促进形成疤痕和初步数据
表明真皮成纤维细胞上存在VEGF接收器,并且这些细胞可以对VEGF做出反应,
拟议研究的中心假设是,VEGF通过直接促进疤痕组织沉积
刺激皮肤成纤维细胞。将执行以下具体目标以检验以下假设:目标1 -
评估VEGF在体外对成纤维细胞功能的影响; AIM 2 - 确定VEGF对成纤维细胞的影响
在体内功能。
尽管有越来越多的证据表明VEGF调节了疤痕的形成,但尚无详细的机理研究
进行了。在这里,新颖的鼠标模型将通过表征来解决知识的差距
VEGF对成纤维细胞的直接影响并解剖VEGF促进疤痕形成的机制。
这些研究结果确定的机制可能延伸到伤口引起的疤痕形成之外,
并有可能在皮肤和其他器官的纤维化调节中发挥作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRACI A WILGUS其他文献
TRACI A WILGUS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRACI A WILGUS', 18)}}的其他基金
Understanding the role of VEGF in scar formation
了解 VEGF 在疤痕形成中的作用
- 批准号:
10437009 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
Evaluation of a novel pro-fibrotic regulatory pathway in the skin
皮肤中新型促纤维化调节途径的评估
- 批准号:
9234862 - 财政年份:2017
- 资助金额:
$ 17.33万 - 项目类别:
Interleukin-33 in skin carcinogenesis
Interleukin-33 在皮肤癌发生中的作用
- 批准号:
8638636 - 财政年份:2013
- 资助金额:
$ 17.33万 - 项目类别:
Mast cells and immunosuppression in skin cancer
皮肤癌中的肥大细胞和免疫抑制
- 批准号:
8386406 - 财政年份:2012
- 资助金额:
$ 17.33万 - 项目类别:
Mast cells and immunosuppression in skin cancer
皮肤癌中的肥大细胞和免疫抑制
- 批准号:
8529528 - 财政年份:2012
- 资助金额:
$ 17.33万 - 项目类别:
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
致癌过程中角质形成细胞对血管内皮生长因子的反应
- 批准号:
7846338 - 财政年份:2009
- 资助金额:
$ 17.33万 - 项目类别:
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
致癌过程中角质形成细胞对血管内皮生长因子的反应
- 批准号:
7499079 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
致癌过程中角质形成细胞对血管内皮生长因子的反应
- 批准号:
8138001 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
致癌过程中角质形成细胞对血管内皮生长因子的反应
- 批准号:
7677951 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
Keratinocyte responses to vascular endothelial growth factor in carcinogenesis
致癌过程中角质形成细胞对血管内皮生长因子的反应
- 批准号:
7915768 - 财政年份:2007
- 资助金额:
$ 17.33万 - 项目类别:
相似国自然基金
优先流对中俄原油管道沿线多年冻土水热稳定性的影响机制研究
- 批准号:42301138
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开放空间内部特征对公共生活行为的复合影响效应与使用者感知机理研究
- 批准号:52308052
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
市场公平竞争与企业发展:指标测度、影响机理与效应分析
- 批准号:72373155
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
气候变暖对青藏高原高寒草甸土壤病毒多样性和潜在功能的影响
- 批准号:32301407
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高温胁迫交叉锻炼对梭梭幼苗耐旱性影响的分子机理研究
- 批准号:32360079
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Bioengineered Composite for the Treatment of Peripheral Arterial Disease
用于治疗外周动脉疾病的生物工程复合材料
- 批准号:
10639077 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
A new large pre-clinical model of aging-related heart failure: a platform to develop new therapies for HFpEF
衰老相关心力衰竭的新型大型临床前模型:开发 HFpEF 新疗法的平台
- 批准号:
10750836 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Fibroadipogenic progenitor cells as drivers of angiogenesis during muscle regeneration
纤维脂肪祖细胞作为肌肉再生过程中血管生成的驱动因素
- 批准号:
10741438 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Extracellular Vesicle Therapy for Diabetic Retinopathy
细胞外囊泡治疗糖尿病视网膜病变
- 批准号:
10723000 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Restoration of Muscular Function Following Direct Muscle Neurotization
直接肌肉神经化后肌肉功能的恢复
- 批准号:
10699345 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别: